WHO joins ivermectin producer in recommending against its use for Covid-19


Modified 1 Apr 2021, 12:41 am

The World Health Organization (WHO) on Wednesday recommended against using generic anti-parasite drug ivermectin in patients with Covid-19 except for clinical trials, because of a lack of data demonstrating its benefits.

The recommendation follows the European Medicines Agency's warning last week against the drug. The US Food and Drug Administration (FDA) has also recommended it not be used for Covid-19...

All Access Plan



per month
Unlimited access to our articles
Comment on all our stories
Gift articles to your friends
Subscribe Now
You can cancel anytime.
Secure and Encrypted
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In